Why the Auscann Group Holdings Ltd share price jumped 25% higher today

The Auscann Group Holdings Ltd (ASX: AC8) share price has been a standout performer on the local market on Thursday.

Its shares rose as much as 25% higher before profit-taking set in. At the time of writing the medicinal cannabis company’s shares are up 12.5% to 76.5 cents.

What happened?

This morning AusCann announced that the Office of Drug Control has granted its partner Tasmanian Alkaloids a manufacturing licence for its Tasmania site.

This means that the medicinal cannabis company is now the only ASX-listed entity to hold all the required licences in Australia to cultivate, harvest, manufacture, and distribute final dose form cannabinoid medicines.

Management believes that the partnership is now positioned to be the predominant supplier of cannabinoid medicines in Australia with future export potential.

AusCann’s managing director Elaine Darby appears to be very bullish on its future prospects, stating that: “The potential Australian medical cannabis market is significant with chronic pain control an initial target for us. There is also real potential for Australia to be an exporter of high quality cost effective cannabis medicines in the future.”

The chronic pain market has previously been estimated by the company to be worth around $5.8 billion a year in Australia.

Is it time to invest?

This is clearly a major positive for the company and arguably gives it a first-mover advantage. However, with so much growth already built into its share price, I intend to hang back and wait to see how its sales generate over the next 12 to 24 months.

If the company’s products can become the standard of care in the chronic pain market then the sky is the limit, but there’s a long road ahead before that becomes a possibility.

Fellow pot stock Hydroponics Company Ltd (ASX: THC) is also up sharply today after signing a licence agreement with National Access Cannabis.

Missed the pot stock boom? Then don't miss out on this even bigger boom.

Bill Gates Says This Could Be Worth “10 Microsofts”

If You Missed Investing In Microsoft in 1996 – Read This

I can’t believe so many investors haven’t heard about something Microsoft founder Bill Gates told a group of college students in 2004.

This could be your chance to get in on the ground floor!

Click here to discover more!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.